Decrease in platelet volume after infusion of highly substituted medium molecular weight hydroxyethyl starch (HES 200/0.62) for several days;ABNAHME DES THROMBOZYTENVOLUMENS NACH MEHRTAGIGER INFUSION VON HOCHSUBSTITUIERTER MITTELMOLEKULARGEWICHTIGER HYDROXYATHYLSTARKE (HAES 200/0,62)

Wiener Klinische Wochenschrift

Volumn 108, Issue 1, 1996, Pages 20-23

  Treib, J ^a   Haass A ^a   Pindur, G ^a   Grauer, M T ^a   Wenzel, E ^a   Schimrigk, K ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

hemodilution; hydroxyethyl starch; platelet volume; platelets

Indexed keywords

HETASTARCH; ANTITHROMBOCYTIC AGENT; PLASMA SUBSTITUTE;

ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEMODILUTION; HUMAN; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE VOLUME; BLOOD; CELL SIZE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

BLOOD PLATELETS; CELL SIZE; CEREBROVASCULAR DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HETASTARCH; HUMANS; INFUSIONS, INTRAVENOUS; LONG-TERM CARE; PLASMA SUBSTITUTES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; TREATMENT OUTCOME;

EID: 0029687731     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abramson N (1988) Plasma expanders and bleeding. Ann Intern Med 108: 307
2. Bessmann JD, Gilmer PR, Gardner FH (1985) Use of mean platelet volume improves detection of platelet disorders. Blood Cells 11: 127-135
3. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G (1993) Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 76: 1185-1190
4. Bredin K, Grun H, Krzywanek HJ, Schremmer WP (1975) Zur Messung der spontanen Thrombozytenaggregation. Plättchenaggregationstest III. Klin Wochenschr 53: 81-89
5. Claes Y, Van Hemelrijck J, Van Gerven M, Arnout J, Vermylen J, Weidler B, Van Aken H (1992) Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anest Analg 75: 24-30
6. Eldor A, Avitzour M, Or R, Hanna R, Penchas S (1982) Prediction of haemorrhagic diathesisin thrombocytopenia by mean platelet volume. Br Med J 285: 397-400
7. Erne P, Wardle J, Sanders K, Lewis SM, Maseri A (1988) Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thrombos Haemostas 59: 259-263
8. Haaß A, Stoll M, Treib J (1991) Hamodilution bei zerebralen Durchblutungsstörungen. Indikationen, Durchführung, medikamentöse Zusatzbehandlung, Alternativen. In: Koscielny J, Kiesewetter H, Jung F, Haaß A (Hrsg) Hämodilution. Neue Aspekte in der Behandlung von Durchblutungsstörungen. Verbesserung in der Makro- und Mikrozirkulation. Springer, Berlin Heidelberg New York Tokyo, S 70-145
9. Harke H, Pieper C, Meredig J, Rahman S, Rüssler P (1980) Rheologische und gerinnungsphysiologische Untersuchungen nach Infusion von HÄS 200/0,5 und Dextran 40. Anaesthesist 29: 71-77
10. Hiippala S, Linko K, Myllylä M, Lalla M, Mäkeläinen A (1991) Albumin, HES 120 und Dextran 70 as adjuvants to red blood cell concentrates: a study on colloid osmotic pressure changes in vitro. Acta Anaesthesiol Scand 35: 654-659
11. Kapiotis S, Quehenberger P, Eichler HG, Schwarzinger I, Partan C (1994) Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 22: 606-612
12. Karpatkin S, Heterogeneity of human platelets (1978) Correlation of platelet function with platelet volume. Blood 51: 307-316
13. Kemona H, Andrzejewska A, Prokopowicz J, Nowak H, Mantur M (1986) Phagocytic activity of human blood platelets examined by electron microscopy. Folia Haematol 113: 696-702
14. Kristensen SD, Milner PC, Martin JF (1988) Bleeding time and platelet volume in acute myocardial infarction - A 2 year follow-up. Thrombos Haemostas 59: 353-356
15. Kuitunen A, Hynynen M, Salmenperä M, Heinonen J, Vahtera E, Verkkala K, Myllylä G (1993) Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand 37: 652-658
16. Levin J, Bessman JD (1983) The inverse relation between platelet volume and platelet number. J Lab Clin Med 101: 295-307
17. Lockwood DNJ, Bullen C, Machin SJ (1988) A severe coagulopathy following volume replacement with hydroxyethylstarch in a Jehovah's witness. Anaesthesia 43: 391-393
18. Popov-Cenic S, Müller N, Kladetzky R-G, Hack G, Lang U, Safer A, Rahlfs VW (1977) Durch Prämedikation, Narkose und Operation bedingte Änderung des Gerinnungs- und Fibrinolysesystems unter den Thrombozyten. Einfluß von Dextran und Hydroxyäthylstärke (HÄS) während und nach Operation. Anaesthesist 26: 77-84
19. Sanfelippo MJ, Suberviola PD, Geimer NF (1987) Development of a von Willebrand like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol 88: 653-655
20. Scheffler P, Jung F, Mrowietz C, Waidhausen P, Leipnitz G, Häuser B (1987) Hämorheologische, mikro- und makrozirkulatorische Effekte einer hypervolämischen Infusion mittelmolekularer Hydroxyäthylstärke (10%, 200000/0,62) bei Gesunden. Infusionstherapie 14: 233-238
21. Scherer P, Giebler R, Kampe S, Knox WJ (1994) Effects of hypertonic saline hydroxyethyl starch solution on collagen-induced platelet aggregation and ATP secretion. Infusionsther Transfusionsmed 21: 310-314
22. Strauß RG, Stansfield C, Henriksen RA, Villhauer PJ (1988) Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 28: 257-260
23. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 50: 509-519
24. Threatte GA (1993) Usefulness of the mean platelet volume. Clin Lab Med 13: 937-950